一步核酸扩增法检测宫颈癌和子宫内膜癌患者淋巴结转移的多中心前瞻性研究
该多中心前瞻性研究评估一步核酸扩增法(OSNA)诊断宫颈癌和子宫内膜癌淋巴结转移的准确性,共纳入133例患者的437枚淋巴结,与常规组织病理学检查相比,OSNA诊断一致率为0.979(95%CI 0.961-0.991),敏感度和特异度分别为0.918(95%CI 0.819-0.973)和0.989(95%CI 0.973-0.997)。作者建议OSNA可作为宫颈癌和子宫内膜癌患者术中快速诊断淋巴结转移的有用工具。
要点
- OSNA与组织病理学检查诊断淋巴结转移的一致率为0.979(95%CI 0.961-0.991)。
- OSNA诊断淋巴结转移的敏感度为0.918(95%CI 0.819-0.973),特异度为0.989(95%CI 0.973-0.997)。
- 作者建议OSNA可作为宫颈癌和子宫内膜癌患者术中快速诊断淋巴结转移的有用工具。
核心结论
- OSNA检测淋巴结转移的准确性与组织病理学检查相当,作者建议其可作为宫颈癌和子宫内膜癌患者术中快速诊断淋巴结转移的有用工具。
研究设计与样本
- 多中心前瞻性研究,纳入133例宫颈癌和子宫内膜癌患者的437枚手术切除淋巴结,沿短轴方向以2mm间隔切片后交替进行OSNA检测和常规组织病理学检查。
- 对OSNA与组织病理学结果不一致的病例,采用苏木精-伊红染色和抗CK19抗体免疫染色进行超分期(200μm淋巴结切片)检查。
主要发现
- 61例患者(14%)经组织病理学检查显示转移,OSNA与组织病理学检查的一致率为0.979(95%CI 0.961-0.991)。
- OSNA检测的敏感度为0.918(95%CI 0.819-0.973),特异度为0.989(95%CI 0.973-0.997)。
- 两种方法在9枚淋巴结(2.1%)中结果不一致,转移灶分配偏倚被确定为不一致的主要原因。
关键数值与推荐
- OSNA与组织病理学检查的一致率为0.979(95%CI 0.961-0.991)。
- OSNA的敏感度为0.918(95%CI 0.819-0.973),特异度为0.989(95%CI 0.973-0.997)。
临床怎么用
- 作者建议OSNA可作为宫颈癌和子宫内膜癌患者术中快速诊断淋巴结转移的有用工具。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This multicenter study aimed to evaluate the accuracy of the one-step nucleic acid amplification (OSNA) assay in diagnosing lymph node metastasis (LNM) in patients with cervical and endometrial cancers. METHODS: Surgically removed LNs from patients with cervical and endometrial cancer were sectioned at 2-mm intervals along the short axis direction and alternately examined using the OSNA assay and conventional histopathological examination. Ultrastaging (200-μm LN sections) was performed for metastatic LNs using hematoxylin and eosin staining and immunostaining with an anti-CK19 antibody in cases where the OSNA assay and histopathological examination (performed using 2-mm LN sections) results showed discordance. RESULTS: A total of 437 LNs from 133 patients were included; 61 patients (14%) showed metastasis by histopathological examination, with a concordance rate of 0.979 (95% confidence interval [CI]: 0.961-0.991) with the OSNA assay. The sensitivity and specificity of the OSNA assay were 0.918 (95% CI: 0.819-0.973) and 0.989 (95% CI: 0.973-0.997), respectively. Discordance between the two methods was observed in nine LNs (2.1%), and allocation bias of metastatic foci was identified as the major cause of discordance. CONCLUSIONS: The OSNA assay showed equally accurate detection of LN metastasis as the histopathological examination. We suggest that the OSNA assay may be a useful tool for the rapid intraoperative diagnosis of LN metastasis in patients with cervical and endometrial cancers.
引用
- Togami S, Tanimoto A, Yanazume S, et al. Evaluation of the one-step nucleic acid amplification assay for detecting lymph node metastasis in patients with cervical and endometrial cancer: A multicenter prospective study. Gynecol Oncol. 2023. PMID: 36638744. doi:10.1016/j.ygyno.2022.12.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。